[Progress in the therapy of leukoses].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008353:Mannitol / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D014265:Triethylenemelamine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008937:Mitomycins; D002699:Chlorambucil; D008353:Mannitol; D014750:Vincristine; D003520:Cyclophosphamide; D014265:Triethylenemelamine; D002066:Busulfan; D001379:Azathioprine; D008727:Methotrexate; D003630:Daunorubicin
Fortschritte in der Therapie der Leukosen.